David Hallal Insider Trading $ALVR Allovir, Inc.
Get free email notifications about insider trading for David Hallal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Hallal. David Hallal is CEO in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Operating Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm. Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP Commercial Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commerical Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Seer, Inc. ($SEER) and Director in Scholar Rock Holding Corp ($SRRK) and Chief Executive Officer in Allovir, Inc. ($ALVR) and Director in iTeos Therapeutics, Inc. ($ITOS).
David Hallal in Allovir, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David Hallal: Chief Executive Officer
Holdings: 2,230,666 shares
Latest Transaction: Jan 25 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Hallal in Allovir, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, ALVR, ITOS, SRRK, SEER
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | A | 45.04 | 273,000 | 12,295,920 | 273,000 | |
| Jan 25 2021 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Grant | A | 0.00 | 147,000 | 0 | 2,230,666 | 2.1 M to 2.2 M (+7.05 %) |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,100,000 | 0 | 0 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | C | 0.00 | 233,333 | 0 | 0 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Buy | C | 0.00 | 738,153 | 0 | 738,153 | 0 to 738.2 K |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Buy | C | 0.00 | 156,577 | 0 | 1,120,965 | 964.4 K to 1.1 M (+16.24 %) |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Buy | C | 0.00 | 13,420,970 | 0 | 13,420,970 | 0 to 13.4 M |
| Jul 31 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | A | 17.00 | 1,101,000 | 18,717,000 | 1,101,000 |
Page: 1